Stoke Therapeutics, Inc. (STOK) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 18 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Oct 29, 2026after close 29 8-K
Q2 FY2026Mon, Aug 3, 2026after close 34 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Mon, Jan 12, 2026before open 12 8-K
Q3 FY2025Tue, Nov 4, 2025after close 35 8-K
Q2 FY2025Tue, Aug 12, 2025after close 43 8-K
Q1 FY2025Tue, May 13, 2025before open 43 8-K
Q4 FY2024Tue, Mar 18, 2025before open 77 8-K

What they guided beta

Q3 FY2026 "Stoke Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Updates –Phase 3 EMPEROR study of zorevunersen, an investigational medicine for Dravet syndrome: ~110 patients through Week 28 primary endpoint, ~20 patients through Week 52 and all continuing into open-label treatment period; data readout anticipated in Q3 2027 followed by the planned U.S. NDA submission in H2 2027– –Successful FDA meeting to align on U.S. NDA submission: Changes in cognition and behavior, a key secondary endpoint in EMPEROR, will be analyzed using a multicomponent assessment of four Vin" exhibit
Q3 FY2026 "Dosing in the first two cohorts is complete and dosing in the third cohort is underway with the fourth cohort expected to follow in early 2027." exhibit
Q3 FY2026 "Dosing is complete in the first two cohorts, with dosing of the third cohort recently initiated and expected to complete by the end of 2026." exhibit
Q3 FY2026 "This cash position is expected to fund operations into early 2028." exhibit
Q3 FY2026 "Dosing of the first two cohorts of patients is complete, with dosing of the third cohort expected to complete by the end of 2026." exhibit
Q2 FY2026 "Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates – Phase 3 EMPEROR study of zorevunersen in Dravet syndrome: Enrollment of 162 patients complete with data readout anticipated in Q3 2027– – Pre-NDA meeting with FDA scheduled for H2 2026; rolling U.S. NDA submission planned to initiate in Q1 2027 – – Phase 1 OSPREY study of STK-002 in patients with ADOA: Dosing complete in sentinel cohort; dose escalation continuing and initial data anticipated in H1 2027– – $420M in cash, cash equivalents and marketable securities based on $354.3M as of June " exhibit
Q2 FY2026 "These data are expected to complete the rolling U.S. NDA submission in the second half of 2027." exhibit
Q2 FY2026 "The first patients are expected to reach Week 52 in August 2026." exhibit
Q2 FY2026 "Data from this cohort are anticipated in the third quarter of 2027 and are expected to be the final clinical data required to complete the planned rolling NDA submission to the FDA." exhibit
Q2 FY2026 "Stoke expects a pre-NDA meeting with the FDA in the second half of 2026 and to initiate the rolling NDA process in the first quarter of 2027, with completion expected in the second half of 2027. o Europe (Germany, France, Spain and Italy): An additional cohort of approximately 30 patients is currently being enrolled in Europe, where the sham control is administered via a needle prick (NP)." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/STOK
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/STOK

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

STOK earnings date badge

HTML

<a href="https://veritasdata.dev/company/STOK/"><img src="https://veritasdata.dev/embed/STOK.svg" alt="STOK earnings date" width="240" height="56"></a>

Markdown

[![STOK earnings date](https://veritasdata.dev/embed/STOK.svg)](https://veritasdata.dev/company/STOK/)

Script

<script async src="https://veritasdata.dev/embed/STOK.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/STOK"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.